Enzo Life Sciences Exendin-4 GLP-1 receptor agonist

Thursday, 12 June, 2014 | Supplied by: United Bioresearch Products Pty Ltd

Enzo Life Sciences Exendin-4 GLP-1 receptor agonist

Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.

Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Cayman Chemical Stem Cell Small Molecule Screening Library

The screening library contains more than 140 small molecules that are known either to induce...

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...

Echelon Biosciences ionisable lipids

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs)...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd